AVCR — Avricore Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$6.08m
- CA$5.84m
- CA$0.53m
Annual cashflow statement for Avricore Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.71 | -0.818 | -0.701 | -0.669 | -1.86 |
| Depreciation | |||||
| Non-Cash Items | 0.534 | 0.34 | 0.708 | 1.34 | 0.767 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.078 | -0.143 | 0.233 | -0.112 | 0.162 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.23 | -0.438 | 0.66 | 1 | -0.79 |
| Capital Expenditures | -0.14 | -1.2 | -1.05 | -0.205 | -0.114 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.01 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.14 | -1.21 | -1.05 | -0.205 | -0.114 |
| Financing Cash Flow Items | -0.099 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.08 | 0.254 | 0.043 | 0.057 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.71 | -1.39 | -0.344 | 0.856 | -0.904 |